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B-1 cells constitute a unique B cell population with distinct ontogenic, phenotypic, and
functional characteristics. Naïve, unmanipulated B-1 cells induce differentiation of CD4+
T cells to become pro-inﬂammatoryTh17 cells whereas naïve B-2 cells do not.We examined
the role of distinctly expressed surface membrane molecules in providing B-1 cells with
Th17-differentiating function. Neither Mac-1, CD25, PD-L2 nor CD73 appeared to contribute
to B-1 cell induction ofTh17 differentiation. In contrast, we found that CD44 and CD86 are
involved on the basis of studies with neutralizing antibodies and knock-out mice. Activation
imparted to naïve B-2 cells the ability to induce Th17 differentiation and this was similarly
partially interrupted by interfering with CD44 and CD86. Our ﬁndings suggest that CD44-
OPN and B7 family members play important roles in the induction ofTh17 cell differentiation
by B cells.
Keywords: B-1 cells, B-2 cells,Th17, CD86, CD44
INTRODUCTION
CD4 T cells differentiate into separate helper, killer, regulatory,
and inﬂammatory populations under the inﬂuence of various
cytokines and cellular interactions that induce expression of spe-
ciﬁc transcription factors (Zhu et al., 2010). In particular, recent
work has identiﬁed a unique Th17 cell population. These T cells
are induced by TGFβ together with IL-6 or IL-21, plus IL-23 (Korn
et al., 2007). Th17 cells produce and secrete one or more members
of the IL-17 family of cytokines along with IL-22, and are charac-
terized by expression of the transcription factors RORγt, RORα,
and STAT3 (Korn et al., 2009). Th17 cells act as intermediaries that
recruit other immune cells and produce inﬂammation that can be
both advantageous in defense against infection and deleterious in
fomenting autoimmunity (Awasthi and Kuchroo, 2009). Aberrant
activity of Th17 cells plays a signiﬁcant role in the pathogenesis of
multiple inﬂammatory and autoimmune disorders, including SLE
(Garrett-Sinha et al., 2008), allergic asthma (Oboki et al., 2008),
inﬂammatory bowel disease (Fujino et al., 2003), and the murine
model for multiple sclerosis, EAE (Komiyama et al., 2006). Thus,
understanding the induction and regulation of Th17 cells is of
paramount importance both from the standpoint of basic science
and clinical medicine.
CD5+ B-1 cells constitute a special B cell population with
distinct ontogenic, phenotypic, and functional characteristics
(Baumgarth, 2011). B-1 cells derive from a unique progenitor and
thus represent a separate lineage (Herzenberg and Tung, 2006;
Montecino-Rodriguez et al., 2006). B-1 cells play a key role in
immune system homeostasis by producing natural antibody that
defends against common infectious pathogens and that disposes
of molecular and cellular debris (Baumgarth et al., 2005; Binder
Abbreviations: CTLA, cytotoxic T lymphocyte-associated antigen; HA, hyaluronic
acid; OPN, osteopontin.
and Silverman, 2005). Further, B-1 cells are thought to inﬂuence
other elements of the immune system, through cytokine produc-
tion and through direct interaction (O’Garra et al., 1992; Ghosn
et al., 2008). Some of these activities may segregate with speciﬁc
B-1 cell populations deﬁned on the basis of surface antigen expres-
sion for Mac-1, CD25, CD73, and PD-L2, the latter of which has
been shown to correlate with autoantibody production (Hastings
et al., 2006; Zhong et al., 2007b, 2009; Ghosn et al., 2008; Tumang
et al., 2011).
In previous work, we found that naïve peritoneal B-1 cells stim-
ulated differentiation of CD4+ T cells to Th17 cells in an allogeneic
co-culture situation (Hastings et al., 2006; Zhong et al., 2007b,
2009; Ghosn et al., 2008; Tumang et al., 2011). In direct contrast,
co-culture of CD4+ T cells with naïve splenic B-2 cells did not yield
Th17 cells but instead produced regulatory T (Treg) cells (Zhong
et al., 2007a). This work was carried out under Treg promoting
cytokine conditions. In the present study, we compared induction
of Th17 cell differentiation produced by B-1 and B-2 cells in the
presence of optimal cytokine conditions, and we determined the
role that uniquely expressed B-1 cell surface antigens might play
in this process.
MATERIALS AND METHODS
MICE
BALB/c, C57BL/6, CD44−/−, B7.1−/−, and B7.2−/− double deﬁ-
cient mice (B7.1/2−/−; all knockout mice are on a C57BL/6
background) were obtained from The Jackson Laboratory. All
mice were cared for and handled in accordance with NIH and
institutional guidelines.
ANTIBODIES AND REAGENTS
Fluorescently labeled antibodies (anti-CD4-FITC,anti-GL7-FITC,
anti-CD21-FITC, anti-B220-FITC, anti-CD23-PE, anti-Mac1-PE,
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anti-CD80-PE, anti-CD86-PE, anti-CD44-PE, anti-Fas-PE,
and anti-CD5-PE-Cy5) were obtained from BD Bioscience. Anti-
OPN, anti-CD44, anti-CD80, anti-CD86, anti-IFNγ, anti-IL-4
antibodies and cytokines IL-2, IL-6, IL-21, IL-23, IL-27 were
obtained from R&D systems. Anti-IL-17a-APC was obtained
from eBioscience. LPS and PMA were obtained from Sigma-
Aldrich. Ionomycin was obtained from Calbiochem. Brefeldin A
was obtained from Enzo.
CELL PREPARATION
Peritoneal washouts and spleens were obtained from 8–10-week-
old mice, and then stained with ﬂuorescence labeled antibodies.
B cell populations (splenic follicular B cell: CD21+/CD23+; peri-
toneal B-1a: B220lo/Mac-1+/CD5+) were then puriﬁed by FACS
using an Inﬂux sorter (BD Bioscience). Flow cytometric analysis
was performed using a LSR-II instrument (BD Bioscience). Naïve
CD4+ T cells were puriﬁed from wild-type mice using the CD4+
T cell isolation kit (Miltenyi Biotec).
IN VITRO Th17 CELL INDUCTION AND INTRACELLULAR
CYTOKINE FLOW CYTOMETRY
Bead-enriched naïve CD4+ T cells were co-cultured at ratio of
2:1 with sort-puriﬁed, irradiated allogeneic B cells in 96-well
round-bottom plates for 5 days in the presence of 10 μg/mL anti-
INFγ, 10 μg/mL anti-IL-4, 3 ng/mL TGFβ, 50 ng/mL IL-6, and
20ng/mL IL-23. Sampleswere stimulatedwith 50 ng/mLPMAand
800 ng/mL ionomycin and 10 μg/mL Brefeldin A for 5 h, before
surface staining with combinations of antibodies against CD4 and
intracellular cytokine staining with antibodies against IL-17A, and
analyzed with a LSR II ﬂow cytometer. All antibodies and stain-
ing buffers were purchased from eBioscience. Cell proliferation
was measured as mean [3H]thymidine incorporation ± SD of
duplicate wells.
RESULTS
B-1 CELLS, BUT NOT B-2 CELLS, INDUCE Th17 CELL DIFFERENTIATION
UNDER OPTIMAL CYTOKINE CONDITIONS
Optimal conditions for Th17 cell differentiation include expo-
sure of CD4+ T cells to TGFβ, IL-6, and IL-23, and blockade of
IFNγ and IL-4. To more fully determine the differences between
B-1 and B-2 cells in Th17 cell differentiation, we compared
the capacity of irradiated, naïve peritoneal B-1 cells and irradi-
ated, naïve splenic B-2 cells to induce Th17 cells in co-culture
experiments under optimal conditions. B cells and T cells were
allogeneically mismatched to more closely model what happens
when T cells are activated by antigen presented in the context of
MHC rather than by antibodies that recognize a TCR complex
component. CD4+ T cells were examined for IL-17 expression
by intracellular staining after 5 days. We found a marked dif-
ference between B-1 and B-2 cells (Figure 1A). Without added
cytokines, B-1 cells induced a modest level of IL-17-containing T
cells. With added cytokines, over one-fourth of T cells expressed
intracellular IL-17. Notably, IL-17+ T cells generally expressed
more CD4 than IL-17- T cells, presumably as a result of acti-
vation and enlargement. In direct contrast, B-2 cells without
added cytokines did not induce Th17 cells and the presence of
cytokines produced only a very small increase in Th17 cells to a
level below that produced by B-1 cells in the absence of cytokines.
Thus, under optimal cytokine conditions B-1 cells potently stim-
ulate Th17 cell differentiation whereas B-2 cells completely fail to
do so.
We examined the inﬂuence of additional cytokines on B-1 cell
induction of Th17 cell differentiation (Figure 1B). We found that
IL-2, IL-10, and IL-27 each inhibited Th17 cell differentiation
(Laurence et al., 2007; Neufert et al., 2007). As expected, IL-21 had
little effect in the presence of IL-6 and, also as expected, retinoic
acid strongly blocked Th17 cell induction (Mucida et al., 2007).
We tested the role of several B-1 cell surface markers and the
subpopulations deﬁned by their expression in promoting Th17
cell differentiation. B-1 cells were divided into those that did
or did not express Mac-1 (CD11b), those that did or did not
express PD-L2, those that expressed high or low levels of CD25,
and those that expressed high or low levels of CD73, as we have
reported (Hastings et al., 2006; Zhong et al., 2007b; Tumang et al.,
2011; Manuscript in preparation). Regardless of the subpopula-
tion examined there was no alteration in B-1 cell stimulation of
Th17 cell differentiation (Figure 1C), strongly suggesting that nei-
ther these molecules nor the subpopulations they deﬁne produce
more or less induction of Th17 cells.
CD86 CONTRIBUTES TO B-1 CELL-INDUCED
Th17 CELL DIFFERENTIATION
Expression of CD80 and CD86 is elevated on B-1 as compared to
B-2 cells, and blockade of CD86 eliminates B-1 cell-induced allo-
geneic stimulation of T cell proliferation (Zhong et al., 2007a).
To investigate the potential role of CD80/CD86 costimulatory
molecules in B-1 cell-induced Th17 cell differentiation, we added
neutralizing anti-CD80 and anti-CD86 antibodies to B and T cells
cultured as above and stained T cells for intracellular IL-17 5 days
later. We found that anti-CD86 partially inhibited induction of
Th17 cells, whereas anti-CD80 did not. However, blockade of
both produced more inhibition than blockade of CD86 alone,
suggesting a role for CD80 that may be masked by a strong
stimulatory effect of intact CD86. To conﬁrm the role of these
co-stimulatory molecules we obtained B-1 cells from CD80−/−
CD86−/− double knockout mice and veriﬁed inhibition of Th17
cell differentiation attributable to these B7 family members.
(Figure 2A)
CD44 CONTRIBUTES TO B-1 CELL-INDUCED
Th17 CELL DIFFERENTIATION
Expression of CD44 is elevated on B-1 as compared to B-2 cells
(Murphy et al., 1990). To investigate the potential role of CD44
in B-1 cell-induced Th17 cell differentiation, we added poly-
clonal neutralizing anti-CD44 antibody to B and T cells cultured
as above and stained T cells for intracellular IL-17 5 days later.
We found that anti-CD44 inhibited induction of Th17 cells by
about half (Figure 2B). Because CD44 can bind both hyaluronic
acid and osteopontin (Lesley et al., 1993; Naor et al., 1997; Ponta
et al., 2003), we used additional neutralizing antibodies to deter-
mine which activity is involved in Th17 cell generation. We found
that anti-osteopontin interfered with B-1 cell-induced Th17 cell
differentiation, whereas an antibody (KM114) that solely inter-
feres with HA binding to CD44 (Greyner et al., 2010) did not.
Frontiers in Immunology | B Cell Biology September 2012 | Volume 3 | Article 281 | 2
“ﬁmmu-03-00281” — 2012/9/10 — 20:09 — page 3 — #3
Wang and Rothstein Th17 differentiation by B-1 cells
FIGURE 1 | B-1 cells, but not B-2 cells, induceTh17 cell differentiation
under optimal cytokine conditions. Sort-puriﬁed BALB/c peritoneal B-1
cells or splenic B-2 cells were co-cultured for 5 days at a 1:2 ratio with
magnetic bead selected CD4+ T cells from C57BL/6 mice in the presence of
medium only or Th17 polarizing cytokines. The percentages of alloactivated
CD4+T cells staining positively for intracellular IL-17 are shown. (A)
Expression of intracellular IL-17 was assessed in CD4+ T cells by ﬂow
cytometry after stimulation by B-1 or B-2 cells in medium only or in the
presence of Th17 polarizing cytokinesTGFβ, IL-6, IL-23 plus anti-IL4 and
anti-IFNγ (Cytokines). Results represent one of 3 comparable experiments.
(B) Expression of intracellular IL-17 was assessed in CD4+ T cells by ﬂow
cytometry after stimulation by B-1 cells in medium only, or with Th17
polarizing cytokines (TGFβ, IL-6, IL-23 plus anti-IL4 and anti-IFNγ in the
absence or presence of 10 ng/mL IL-2 (2), 10 ng/mL IL-10 (10), 10 ng/mL IL-21
(21), 10 ng/mL IL-27 (27) or 1 μM/mL retinoic acid (RA), as indicated. Mean
values are shown along with lines indicating SEMs (n = 3). (C) Expression of
intracellular IL-17 was assessed in CD4+ T cells exposed toTh17 polarizing
cytokines and stimulated by B-1 cells or by sort-puriﬁed subpopulations of B-1
cells including CD25high (CD25hi) vs CD25low (CD25lo), Mac-1 positive
(Mac+) vs Mac-1 negative (Mac−), CD73 high (CD73hi) vs CD73low
(CD73lo), and, PD-L2 positive (L2+) vs PD-L2 negative (L2−). Mean
values are shown along with lines indicating SEMs (n = 3). t -Test was
performed to determine whether differences were signiﬁcant. **p < 0.01;
*p < 0.05.
Because CD44 can participate in cell–cell interaction (Siegelman
et al., 1999), we examined allogeneic stimulation of T cell pro-
liferation by B-1 cells in the presence or absence of these various
antibodies to separate effects on T cell differentiation from general
effects of B:T interaction. We found that none of the antibodies
interfered with the ability of B-1 cells to drive T cell prolifera-
tion and thus did not prevent T cells from interacting with B cells
(Figure 2C).
To conﬁrm the role of CD44 we obtained B-1 cells from
CD44−/− knockout mice and veriﬁed inhibition of Th17 cell
differentiation attributable to B-1 cell expression of this surface
molecule (Figure 2D). At the same time we obtained CD4+ T cells
fromCD44−/− knockoutmice and veriﬁed inhibition of Th17 cell
differentiation attributable to T cell CD44 expression (Figure 2E).
Thus,CD44participates speciﬁcally inB-1 cell stimulationof Th17
cell differentiation via its osteopontin binding activity, and CD44
on both B-1 cells and T cells is important.
ACTIVATED B-2 CELLS STIMULATE Th17 CELL
DIFFERENTIATION LIKE B-1 CELLS
The expression of CD44, CD86, and CD80 is increased dramati-
cally on B-2 cells by mitogenic stimulation (Murphy et al., 1990;
Hathcock et al., 1994). Inasmuch as CD44, CD86, and CD80 are
responsible, at least in part, for the ability of B-1 cells to induce
Th17 cell differentiation, activated B-2 cells may acquire this abil-
ity as well. To test this possibility, we stimulated sort-puriﬁed naïve
splenic B-2 cells with 10 μg/mL LPS for 48 h and then co-cultured
activated B-2 cells with MHC-disparate CD4+ T cells in the pres-
ence of medium or optimal Th17 polarizing conditions. After 5
days T cells were stained for intracellular IL-17. We found that
activated B-2 cells strongly induced Th17 cell differentiation, even
exceeding the induction produced by naïve B-1 cells (Figure 2F)
and highly expressed CD80, CD86 and CD44 (Figures 3A–C).
To evaluate the role of LPS-stimulated expression of CD44 and
B7 family members in this process, we co-cultured activated B-2
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FIGURE 2 | CD44 and CD86 contribute to B-1 cell-inducedTh17 cell
differentiation. (A) Sort-puriﬁed C57BL/6 peritoneal B-1 cells were
co-cultured at a 1:2 ratio with magnetic bead selected CD4+ T cells from
BALB/c mice in the presence of Th17 polarizing conditions with or without
neutralizing antibodies directed against CD80 (αCD80) or CD86 (αCD86) or
both, or with isotype control antibody (IC), as indicated. Sort-puriﬁed
peritoneal B-1 cells from CD80/CD86 double knock-out mice on the C57BL/6
background (DKO) were co-cultured at a 1:2 ratio with magnetic bead
selected CD4+ T cells from BALB/c mice. After 5 days expression of
intracellular IL-17 was assessed by ﬂow cytometry. Mean values are shown
along with lines indicating SEMs (n = 3). (B) Sort-puriﬁed BALB/c B-1 cells
were co-cultured at a 1:2 ratio with magnetic bead selected CD4+ T cells
from C57BL/6 mice in the presence of Th17 polarizing conditions with either
isotype control antibody (IC), polyclonal anti-CD44 antibody (αCD44p), KM114
monoclonal anti-CD44 antibody (KM114), or anti-OPN antibody (αOPN), each
at 10 μg/mL. After 5 days expression of intracellular IL-17 was assessed by
ﬂow cytometry. Mean values are shown along with lines indicating SEMs
(n = 3). (C) Comparable cultures as described in B were harvested at 3 days
after addition of [3H]thymidine during the last 6 h of culture. Mean cpm
values of triplicate cultures in three independent experiments are shown
along lines indicating SEMs. (D) Sort-puriﬁed peritoneal B-1 cells from
C57BL/6 (CTL) or CD44 KO mice were co-cultured at a 1:2 ratio with
magnetic bead selected CD4+ T cells from BALB/c mice in Th17 polarizing
conditions. After 5 days expression of intracellular IL-17 was assessed by ﬂow
cytometry. Mean values are shown along with lines indicating SEMs (n = 3).
(E) Sort-puriﬁed peritoneal B-1 cells from BALB/c mice were co-cultured at a
1:2 ratio with magnetic bead selected CD4+ T cells from C57BL/6 (CTL) or
CD44 KO mice in Th17 polarizing conditions. After 5 days expression of
intracellular IL-17 was assessed by ﬂow cytometry. Mean values are shown
along with lines indicating SEMs (n = 3). (F) Sort-puriﬁed peritoneal B-1 cells
and splenic B-2 cells were cultured for 5 days in medium, and sort-puriﬁed
splenic B-2 cells were cultured for 5 days with 10 μg/mL LPS (B-2-LPS).
Harvested supernatants were assayed for osteopontin (OPN). Mean
values are shown along with lines indicating SEMs (n = 3). t -Test was
performed to determine whether differences were signiﬁcant. **p < 0.01;
*p < 0.05.
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FIGURE 3 | Activated B-2 cells stimulateTh17 cell differentiation like B-1
cells. (A–C) Peritoneal B-1 cells and splenic B-2 cells were evaluated for
expression of CD80 (A), CD86 (B), and CD44 (C) by immunoﬂuorescent
staining and ﬂow cytometry. Splenic B-2 cells were sort-puriﬁed and
stimulated by 10 μg/mL LPS and then similarly evaluated. Mean values are
shown along with lines indicating SEMs (n = 3). (D,E) Sort-puriﬁed BALB/c
peritoneal B-1 cells (a,b) and splenic B-2 cells previously stimulated by
10 μg/mL LPS (c–f) were co-cultured at a 1:2 ratio with magnetic bead
selected CD4+ T cells from CD57BL/6 mice in Th17 polarizing conditions in
medium alone (a,c) or in the presence of anti-CD44 antibody (d), anti-CD80
plus anti-CD86 antibody (e) or anti-osteopontin antibody (b,f). After 5 days
expression of intracellular IL-17 was assessed by ﬂow cytometry.
Representative results are shown in (D) and mean values (with horizontal
lines indicating SEM) for ﬁve independent experiments are shown in (E). In
(A,B,C,E), t -test was performed to determine whether differences were
signiﬁcant. **p < 0.01; *p < 0.05.
cells with naïve T cells in the presence of neutralizing antibodies
directed against CD44, CD80/86, and osteopontin. We found that
each of these antibodies produced an approximately 40% decline
in Th17 cell induction (Figure 3D,E). Thus, naïve B-1 cells are
capable of inducing Th17 cell differentiation as are activated (but
not naïve) B-2 cells and key surface molecules including CD44
(osteopontin), CD86 and CD80 are involved in the induction of
Th17 cells by B cells whether acquired natively (B-1 cells) or as a
result of activation (B-2 cells).
DISCUSSION
Antigen-presenting cells (APC) are principal architects of the
immune response by orchestrating T cell priming and differen-
tiation. Much effort has been focused on understanding the role
and function of dendritic cells (DC) in these processes. Although
B cells are also considered professional APC, previous work has
focused primarily on their role as terminal effectors of antibody
production dependent on the help of DC-primed T cells, whereas
their role in T cell priming, differentiation, and tolerance has been
controversial.
Recent evidence has highlighted the role of Treg cells in the
induction and maintenance of peripheral tolerance and, con-
versely, the role of Th17 cells as effectors of inﬂammatory
responses. Besides naturally occurring Treg (nTreg) cells, induced
Treg (iTreg) cells canbe converted fromnaïveT cells in thepresence
of TGFβ. Such conversion also requires APC-derived costimu-
latory signals in addition to TCR engagement. We questioned
whether B cells function asAPC in the generation of Th17 cells and
what surfacemoleculesmight be involved.We focused onB-1 cells,
a distinct B cell subset that produces protective natural antibody
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and that differs from B-2 cells in many respects including lin-
eage, location, gene expression, antibody repertoire, proliferative
responses, and immunoglobulin secretion.
In recent years a role for B cells has been delineated in a
number of autoimmune and inﬂammatory diseases, which has
led to successful application of B cell depletion therapies in
some (Perosa et al., 2010). The results presented here empha-
size the capacity of naïve B-1 cells and activated B-2 cells to
induce differentiation of IL-17 expressing pro-inﬂammatory Th17
cells, raising the possibility that participation in Th17 cell induc-
tion represents a mechanism by which B cells may contribute
to autoimmune and inﬂammatory disease. Our results further
indicate that osteopontin-binding CD44 plays a major role in
the pathway from B cells to Th17 cells in vitro, which ﬁts well
with recent results indicating a role for CD44/osteopontin in pro-
moting Th17 cell differentiation in vivo (Guan et al., 2011). This
latter work did not determine how T cells were stimulated to
undergo Th17 cell differentiation, which the work presented here
suggests may come about through B cell:T cell interaction. B-1
cells are known to produce IL-10 (O’Garra et al., 1992) and the
inﬂuence of CD44/osteopontin may result, in part, from inhi-
bition of immunosuppressive IL-10 secretion (Murugaiyan et al.,
2008) that allows for more robust T cell stimulation. This mech-
anism may also contribute to disease which has been shown in
mouse and human to be associated with osteopontin (Iizuka et al.,
1998; Forton et al., 2002; Jansson et al., 2002; Yumoto et al., 2002;
Xu et al., 2005).
In summary, our ﬁndings suggest that CD44/osteopontin and
CD86/CD80 costimulatory molecules play a crucial role in the
induction of Th17 cells by B cells. These data show that B-1
cells and activated B-2 cells can direct and regulate the inﬂam-
matory response through Th17 induction. To the extent that
they do so, B cell depletion therapy may reset the balance
between effector and regulatory populations of T cells as well as
B cells.
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